BioSpace News Archive

Rotech Healthcare Inc. (Rotech) entered into a new $315 million amended and restated credit agreement with a diversified group of lenders including SunTrust Bank as administrative agent and issuing lender and SunTrust Robinson Humphrey, Inc., Regions Bank, and Fifth Third Bank, as joint lead arrangers and bookrunners and Citizens Bank as Documentation Agent

Company Also Receives CE Mark for the VASCADE MVP for Multi-Site Vessel Closure Following Electrophysiology Procedures

Joseph Miller, MD, MS, a physician at the Henry Ford Health System in Detroit, MI, and a key Principal Investigator on CalciMedica’s initial acute pancreatitis clinical study of its calcium release-activated calcium channel inhibitor CM4620-IE, presented on the study at the annual meeting of the American College of Emergency Physicians being held in Denver, CO from October 27-30.

The U.S. Department of Agriculture, the U.S. Environmental Protection Agency, and the U.S. Food and Drug Administration announced a new partnership with the Food Waste Reduction Alliance, the latest effort in the Winning on Reducing Food Waste Initiative launched by the three federal agencies in 2018.

Retia Medical, LLC announced today that three of the top five U.S. hospitals completed a purchase of a large number of Argos Hemodynamic Monitors.

Ranbaxy Pharmaceuticals Canada Inc. is recalling all lots of its prescription ranitidine products from the Canadian market as a precautionary measure.

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, announced the appointment of seasoned life sciences executive Peter Soparkar as chief legal officer.

Conformis, Inc., a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific joint replacement implants designed to fit each patient’s unique anatomy, announced financial results for the third quarter ended September 30, 2019.

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company developing novel precision antibacterials to treat serious drug-resistant infections, announced the appointment of David Altarac, M.D., MPA as Chief Medical Officer, effective November 4, 2019.

MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced that the Company will release its financial results for the third quarter of 2019 after the market closes on Wednesday, November 6, 2019.